SANTOS DA SILVA JORGE (Chief Executive Officer) received a stock award from MOONLAKE IMMUNOTHERAPEUTICS
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2025ACC: 0001213900-25-019674
DirectorOfficer· Chief Executive Officer
Since Apr 2022
+95.76K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
95.76K acquired
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
+95.76K
Price / share
—
Trade value
—
% of position
3.2%
2/27/2025
2.98M→3.08M
Total
Net shares
+95.76K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 2/27/2025 | A · Award | +95.76K | — | — | 3.2% | 2.98M | 3.08M |
| Total | +95.76K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported